Chunde Li

Publications
CV
Public outreach and news

Articles

Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(5):395-405

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Antonarakis ES; Piulats JM; Gross-Goupil M; Goh J; Ojamaa K; Hoimes CJ; Vaishampayan U; Berger R; Sezer A; Alanko T; de Wit R; Li C; Omlin A; Procopio G; Fukasawa S; Tabata K-I; Park SH; Feyerabend S; Drake CG; Wu H; Qiu P; Kim J; Poehlein C; de Bono JS
Article: PLOS ONE. 2016;11(1):e0145545

Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material.

Peng Z; Andersson K; Lindholm J; Dethlefsen O; Pramana S; Pawitan Y; Nistér M; Nilsson S; Li C
Article: SPRINGERPLUS. 2016;5(1):1861

Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells.

Ma Y; Miao Y; Peng Z; Sandgren J; De Ståhl TD; Huss M; Lennartsson L; Liu Y; Nistér M; Nilsson S; Li C
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2014;17(1):81-90

An expression signature at diagnosis to estimate prostate cancer patients' overall survival.

Peng Z; Skoog L; Hellborg H; Jonstam G; Wingmo I-L; Hjälm-Eriksson M; Harmenberg U; Cedermark GC; Andersson K; Ahrlund-Richter L; Pramana S; Pawitan Y; Nistér M; Nilsson S; Li C
Article: PLOS ONE. 2014;9(10):e109610

Operator dependent choice of prostate cancer biopsy has limited impact on a gene signature analysis for the highly expressed genes IGFBP3 and F3 in prostate cancer epithelial cells.

Peng Z; Andersson K; Lindholm J; Bodin I; Pramana S; Pawitan Y; Nistér M; Nilsson S; Li C
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2010;29(1):162

XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells.

Xing Z; Zhou Z; Yu R; Li S; Li C; Nilsson S; Liu Z
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2008;16(12):1521-1525

Influence of MUC1 genetic variation on prostate cancer risk and survival.

Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
Article: GROWTH HORMONE & IGF RESEARCH. 2007;17(5):392-398

GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder.

Strawbridge RJ; Kärvestedt L; Li C; Efendic S; Ostenson CG; Gu HF; Brismar K
Article: CANCER RESEARCH. 2007;67(18):8504-8510

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.

Lapointe J; Li C; Giacomini CP; Salari K; Huang S; Wang P; Ferrari M; Hernandez-Boussard T; Brooks JD; Pollack JR
Article: MODERN PATHOLOGY. 2007;20(4):467-473

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.

Lapointe J; Kim YH; Miller MA; Li C; Kaygusuz G; van de Rijn M; Huntsman DG; Brooks JD; Pollack JR
Article: CANCER RESEARCH. 2005;65(18):8118-8124

The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.

Kim H; Lapointe J; Kaygusuz G; Ong DE; Li C; van de Rijn M; Brooks JD; Pollack JR
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(3):811-816

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; Montgomery K; Ferrari M; Egevad L; Rayford W; Bergerheim U; Ekman P; DeMarzo AM; Tibshirani R; Botstein D; Brown PO; Brooks JD; Pollack JR
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;22(5):1003-1007

Mutation analysis of the BRG1 gene in prostate cancer clinical samples.

Valdman A; Nordenskjöld A; Fang X; Naito A; Al-Shukri S; Larsson C; Ekman P; Li C
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2003;11(4):529-533

Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.

Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber J-E; Larsson C; Ekman P
Article: ONCOGENE. 2000;19(11):1392-1399

Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma.

Alimov A; Kost-Alimova M; Liu J; Li C; Bergerheim U; Imreh S; Klein G; Zabarovsky ER
Article: EUROPEAN UROLOGY. 2000;37(3):358-365

Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.

Marano A; Pan Y; Li C; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
Article: ANTICANCER RESEARCH. 1999;19(5B):3841-3846

Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.

Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Article: PROSTATE. 1999;39(4):262-268

Links between genetic and environmental factors and prostate cancer risk.

Ekman P; Grönberg H; Matsuyama H; Kivineva M; Bergerheim US; Li C
Article: GENES CHROMOSOMES & CANCER. 1999;24(3):175-182

Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.

Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim US
Article: PROSTATE. 1998;36(1):31-38

Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer.

Pan Y; Matsuyama H; Wang N; Yoshihiro S; Häggarth L; Li C; Tribukait B; Ekman P; Bergerheim US
Article: ONCOGENE. 1998;16(4):481-487

Identification of two distinct deleted regions on chromosome 13 in prostate cancer.

Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim US
Article: HUMAN MUTATION. 1998;Suppl 1:s31-s33

Germline mutations detected in the von Hippel-Lindau disease tumor suppressor gene by Southern blot and direct genomic DNA sequencing.

Li C; Weber G; Ekman P; Lagercrantz J; Norlen BJ; Akerström G; Nordenskjöld M; Bergerheim US
Article: CANCER GENETICS. 1996;86(2):95-101

Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell lines.

Bergerheim US; Söderhäll M; Zabarovsky E; Franzén B; Manneborg-Sandlund A; Li C; Jacobson SH; Auer G; Klein G; Collins VP
Article: CYTOGENETIC AND GENOME RESEARCH. 1996;75(1):17-21

Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization.

Bentz M; Bergerheim US; Li C; Joos S; Werner CA; Baudis M; Gnarra J; Merino MJ; Zbar B; Linehan WM; Lichter P
Show more

All other publications

Corrigendum: SPRINGERPLUS. 2016;5(1):2084

Erratum to: Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells.

Ma Y; Miao Y; Peng Z; Sandgren J; De Ståhl TD; Huss M; Lennartsson L; Liu Y; Nistér M; Nilsson S; Li C
Published conference paper: BRITISH JOURNAL OF UROLOGY. 1997;79 Suppl 2:35-41

Environmental and genetic factors: a possible link with prostate cancer.

Ekman P; Pan Y; Li C; Dich J

Employments

Affiliated to Research, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2024-2027

Degrees and Education

Docent, Karolinska Institutet, 2015
Doctor Of Philosophy, Dept of Surgical Science, Karolinska Institutet, 1999

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI